Effect of vitamin D and/or omega-3 fatty acid supplementation on stroke outcomes: A randomized trial.
Effect of vitamin D and/or omega-3 fatty acid supplementation on stroke outcomes: A randomized trial.
复制标题
补充维生素D和/或ω-3脂肪酸对卒中结局的影响:一项随机试验。
DOI:
10.1111/ene.14623
复制
发表时间:
2021-03
影响因子:
5.1
通讯作者:
Rexrode KM
中科院分区:
文献类型:
--
作者:
Rist PM;Buring JE;Cook NR;Manson JE;Rexrode KM
Among stroke patients, low serum 25-hydroxyvitamin D (25[OH]D) predicts poor outcomes. In mice, higher omega-3 (n-3) fatty acid intake diminishes brain damage after stroke. However, few studies have examined effects of supplementation with vitamin D or n-3 prior to stroke on post-stroke outcomes. We used data from the VITamin D and OmegA-3 TriaL which randomized middle-aged and older men and women without cardiovascular disease to vitamin D3 (2000 IU/day) and/or marine n-3 fatty acids (1 g/day) and followed them for incident stroke events. Individuals experiencing a non-fatal stroke were mailed questionnaires assessing functional limitations (the physical performance scale adapted from Nagi) and physical disability (the modified Katz Activities of Daily Living and Rosow-Breslau Functional Health scales). We used logistic regression to analyze associations between randomized treatment and limitations on each scale. 290 individuals experienced their first stroke during the trial. 197 stroke survivors completed the stroke outcomes questionnaire a median of 1.4 years after diagnosis. We observed no associations between randomized treatment to vitamin D and functional limitations (odds ratio [OR]=1.01, 95% confidence interval [CI]: 0.52, 1.97) or physical disability (Rosow-Breslau - OR=0.92, 95% CI: 0.50, 1.67; Katz - OR=1.03, 95% CI: 0.31, 3.42). Those randomized to n-3 had a non-significantly lower risk of functional limitations (OR=0.55, 95% CI: 0.28, 1.09) and physical disability (Rosow-Breslau - OR=0.56, 95% CI: 0.31, 1.02; Katz - OR=0.32, 95% CI: 0.50, 1.67). Vitamin D or omega-3 fatty acids supplementation prior to stroke did not result in significantly improved post-stroke outcomes.
登录
查看更多内容
DOI:
10.1056/nejmoa1811403
发表时间:
2019-01-03
期刊:
The New England journal of medicine
影响因子:
--
作者:
Manson JE;Cook NR;Lee IM;Christen W;Bassuk SS;Mora S;Gibson H;Albert CM;Gordon D;Copeland T;D'Agostino D;Friedenberg G;Ridge C;Bubes V;Giovannucci EL;Willett WC;Buring JE;VITAL Research Group
通讯作者:
VITAL Research Group
影响因子:
7.4
作者:
Cai M;Zhang W;Weng Z;Stetler RA;Jiang X;Shi Y;Gao Y;Chen J
通讯作者:
Chen J
影响因子:
--
作者:
Sari, Aylin;Durmus, Bekir;Aktas, Ilknur
通讯作者:
Aktas, Ilknur
影响因子:
12.7
作者:
Allaire, SH;LaValley, MP;Felson, DT
通讯作者:
Felson, DT
影响因子:
5.8
作者:
Li, Y. -Y.;Wang, Y. -S.;Zhang, J. -M.
通讯作者:
Zhang, J. -M.